We are only able to display limited information for this firm. We display more complete information for all of the following firms:
With a balanced split between patent prosecution, counselling, and litigation, Casalonga offers its clients a comprehensive and international service that handles the full spectrum of issues including complex litigation before French courts, national courts, EU IP offices, and even foreign courts and rightfully earns its place as a revered player in the industry. The firm’s patent law offering is split by industry, with a mechanics team headed up by Olivier Delprat and Julien Thon. The electronics and ICT team is co-headed by Ghislain de Tremiolles, Francis Zapalowicz, and Augustin Le Tourneau. Finally, Gwennhaël Le Roy and Virginie Martin-Charbonneau chair the chemistry team while Jean-Baptiste Lecoeur handles the pharmaceuticals and life-sciences work. Jürgen Neugebauer heads the firm’s Munich office, while Arnaud Casalonga , Caroline Casalonga, Marianne Gabriel and Pascaline Vincent manage the firm’s patent litigation team.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The Patents team at Casalonga is solid and efficient. During several patent disputes in the pharmaceutical field, we were able to appreciate the quality of the work and discussions with the team at Casalonga.'
‘The team is very competent and available at all times.’
Key clients
- Adeo Group
- Arkema
Work highlights
Defended SAGEMCOM against Intellectual Ventures in one of the most important FRAND matters in the telecom industry.
Represented BIOGARAN in several oppositions filed before the EPO in the field of pharmaceutical patents, notably the patents protecting “Everolimus” and its medical uses owned by Novartis and patents protecting pharmaceutical compositions based on a product called “Cinacalcet” owned by Amgen